Jannick Bendtsen

Don’t sleep on the legend that is Jannick Bendtsen. This guy is straight-up the real deal in biotech and bioinformatics. Dude’s been in the game for over 15 years, crushing it in the world of molecular biology and data science. He’s got a Ph.D. from DTU, so the guy’s legit scientifically, but what’s crazy is how he’s taken all that deep knowledge and turned it into startups that actually matter.

He’s been around the block with some heavy hitters, worked at CLC bio, which got bought by QIAGEN, and at Cartagenia, snagged by Agilent. Plus, he was at Biomatters, which got snapped up by GraphPad. Basically, he’s got a track record of building stuff that big players want, and he knows how to sell it. That’s not easy, but he’s done it multiple times.

Then, in 2020, Jannick jumped into the deep end with PipeBio. He saw a problem, drug development is a pain, especially with antibodies and peptides, and decided to build a cloud-based SaaS platform to make it way easier. No-code, super user-friendly, and designed for the scientists who actually do the work. The thing blew up fast, got seed funding from byFounders, YC (W21, shoutout!), and Acequia, and just kept pushing forward.

What’s wild is, PipeBio didn’t just stay small. They got acquired by Benchling, which is a huge deal. That move proves Jannick’s got the vision and execution chops, knowing when to grow, when to sell, and how to stay ahead of the curve. And honestly, he’s all about having an effect, not just chasing tech fame. He’s customer-focused, razor-sharp on product, and always pushing biotech boundaries to the limit.

Bottom line? Jannick’s story is about a guy who’s been through the startup wars, learned what works, and now he’s shaping the future of drug discovery tech. Dude’s got the perfect mix of hardcore science and startup hustle. No cap, he’s someone you wanna watch if you’re into biotech, startups, or just seeing how real innovation happens.